Biotest GmbH & Co. KGaA Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-24.5	26.4	127	-31.7	-63.4	-31.4
Depreciation & Amortization	40.5	40.5	35.8	35.8	31.1	29.7
Other Amortization	0.1	0.1	0.1	-	-	-
Loss (Gain) From Sale of Assets	-0.1	-0.1	-23.1	-	-	0.2
Loss (Gain) From Sale of Investments	-	-	-	-	-	-4.7
Loss (Gain) on Equity Investments	14	14	-2.4	0.7	-1.3	0.5
Provision & Write-off of Bad Debts	-7.9	-7.9	-	-	-	-
Other Operating Activities	-34.1	-11.9	28.4	-0.1	45.9	21.8
Change in Inventory	-11.4	-11.4	-213.4	-76.1	23.8	-29.9
Change in Accounts Payable	7	7	45.3	24.8	-	-4.9
Change in Other Net Operating Assets	30.8	4.2	-0.4	6.1	-2.3	2
Operating Cash Flow	14.4	60.9	-2.7	-40.5	33.8	-16.7
Operating Cash Flow Growth	-37.39%	-	-	-	-	-
Capital Expenditures	-28.7	-28.7	-33.4	-29.3	-18.2	-27
Sale of Property, Plant & Equipment	0.2	0.2	1	-	0.3	0.1
Divestitures	-	-	35	-	-	-
Investment in Securities	1.7	1.7	-2.4	-7.8	-5.5	11.5
Other Investing Activities	9.9	1.1	1.1	0.1	-	0.8
Investing Cash Flow	-16.9	-25.7	1.3	-37	-23.4	-14.6
Long-Term Debt Issued	-	197.4	10.1	100	25.1	50
Long-Term Debt Repaid	-	-230.2	-19	-5.8	-5.3	-7.3
Net Debt Issued (Repaid)	-32.8	-32.8	-8.9	94.2	19.8	42.7
Common Dividends Paid	-1.6	-1.6	-	-0.8	-0.8	-0.8
Other Financing Activities	-6	-1	2.1	-3.8	3.6	0.1
Financing Cash Flow	-40.4	-35.4	-6.8	89.6	22.6	42
Foreign Exchange Rate Adjustments	-0.1	-0.1	0.1	-	-	-0.2
Miscellaneous Cash Flow Adjustments	-	-	-0.4	0.1	0.1	-
Net Cash Flow	-43	-0.3	-8.5	12.2	33.1	10.5
Free Cash Flow	-14.3	32.2	-36.1	-69.8	15.6	-43.7
Free Cash Flow Margin	-2.25%	4.43%	-5.27%	-13.53%	3.03%	-9.03%
Free Cash Flow Per Share	-0.36	0.81	-0.91	-1.76	0.39	-1.10
Cash Interest Paid	14.5	20.3	24.2	13.1	12.8	6.6
Cash Income Tax Paid	8.7	8.7	11.7	2	0.9	2
Levered Free Cash Flow	-30.99	-5.79	-68.74	-71.69	28.64	-61.04
Unlevered Free Cash Flow	-12.3	13.15	-45.86	-60.13	36.39	-52.85
Change in Working Capital	26.4	-0.2	-168.5	-45.2	21.5	-32.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.